Skip to main content
. 2020 Nov 18;12(22):23165–23186. doi: 10.18632/aging.104088

Figure 6.

Figure 6

Risk score analysis of the 11 metabolic gene signature-based prognostic model in the training group ccRCC patients. (A) Kaplan-Meier survival curve analysis shows the overall survival of high- (n=190) and low-risk (n=191) training group ccRCC patients based on the median risk score calculated using the 11 metabolic genes-based prognostic model. (B) Time dependent ROC curve analysis shows the prognostic performance of the 11-metabolic gene signature-based prognostic model in predicting 1-year, 3-year, and 5-year survival times of the high- and low-risk training group ccRCC patients. (C) Heat map shows the expression of the 11 metabolic genes in high- and low-risk training group ccRCC patients. (D) Risk curve analysis of the 11 metabolic genes in high- and low-risk training group ccRCC patients.